S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

MaxCyte (MXCT) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free mxct Stock Alerts
$3.95
+0.07 (+1.80%)
(As of 05:37 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 7
After Market Closes
Confirmed
Actual EPS
(Mar. 12)
-$0.05 Beat By $0.05
Consensus EPS
(Mar. 12)
-$0.10
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MXCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MXCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MaxCyte Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.15)($0.15)($0.15) 
Q2 20241($0.15)($0.15)($0.15) 
Q3 20241($0.15)($0.15)($0.15) 
Q4 20241($0.14)($0.14)($0.14) 
FY 20244($0.59)($0.59) ($0.59)

MXCT Earnings Date and Information

MaxCyte last announced its earnings data on March 12th, 2024. The reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.05. The company earned $15.67 million during the quarter, compared to the consensus estimate of $15.60 million. MaxCyte has generated ($0.37) earnings per share over the last year (($0.37) diluted earnings per share). Earnings for MaxCyte are expected to grow in the coming year, from ($0.53) to ($0.46) per share. MaxCyte has confirmed that its next quarterly earnings report will be published on Tuesday, May 7th, 2024. MaxCyte will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

MaxCyte Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/7/2024
Confirmed)		-------  
3/12/2024Q4 2023($0.10)($0.05)+$0.05($0.05)$15.60 million$15.67 million
11/8/2023Q3 2023($0.10)($0.11)($0.01)($0.11)$7.90 million$8.01 million
8/9/2023Q2 2023($0.10)($0.10)-($0.10)$11.00 million$9.04 million
5/10/2023Q1 2023($0.11)($0.11)-($0.11)$8.75 million$8.58 million
3/15/2023Q4 2022($0.06)($0.05)+$0.01($0.05)$13.15 million$12.42 million
11/9/2022Q3 2022($0.09)($0.06)+$0.03($0.06)$10.40 million$10.64 million
8/10/2022Q2 2022($0.08)($0.08)-($0.08)$9.00 million$9.61 million
5/9/2022Q1 2022($0.07)($0.04)+$0.03($0.04)$11.00 million$11.59 million
3/22/2022Q4 2021($0.05)($0.05)-($0.05)$9.30 million$10.15 million    
11/10/2021Q3 2021($0.05)($0.03)+$0.02($0.03)$7.25 million$10.14 million
9/13/2021Q2 2021($0.05)($0.05)-($0.05)$5.95 million$7.11 million

MaxCyte Earnings - Frequently Asked Questions

When is MaxCyte's earnings date?

MaxCyte has confirmed that its next quarterly earnings data will be published on Tuesday, May 7th, 2024. Learn more on MXCT's earnings history.

Did MaxCyte beat their earnings estimates last quarter?

In the previous quarter, MaxCyte (NASDAQ:MXCT) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.10) by $0.05. Learn more on analysts' earnings estimate vs. MXCT's actual earnings.

How much revenue does MaxCyte generate each year?

MaxCyte (NASDAQ:MXCT) has a recorded annual revenue of $41.29 million.

How much profit does MaxCyte generate each year?

MaxCyte (NASDAQ:MXCT) has a recorded net income of -$37.92 million. MXCT has generated -$0.37 earnings per share over the last four quarters.

What is MaxCyte's EPS forecast for next year?

MaxCyte's earnings are expected to grow from ($0.53) per share to ($0.46) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:MXCT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
How Biden has already won 2024
Porter & Company